Download Technology Capabilities
Since 2016, the biotechnology industry has faced unprecedented uncertainty in both Europe and the United States with new competition coming from China and tech-giants. in order to stay ahead Biotech companies will need to leverage and incorporate emerging digital technologies into their R&D processes, or be replaced by those who do. Access to relevant insights, both real time and even faster is imperative if you want to stay innovative and make novel discoveries in less time. Innoplexus’ technology empowers biotechs with an automated search in the biggest life science data ocean consisting of 97% of publicly available data. To the point access to applicable life science data allows biotechs to generate faster insights, discover new connections between biological entities and also identify KOLs – on a fingertip. This would help the industry save both time and costs.
The OntosightTM platform for life sciences harnesses artificial intelligence (AI) to provide fully automated concept-based search on publicly available data from sources such as publications, congresses, clinical trials, etc. OntosightTM enriches and continually analyses data by means of our proprietary life sciences ontology. Our ontology establishes relationships between biological entities such as genes, proteins, diseases, and drugs, helping to contribute to the discovery of new connections. The user gets real-time updates and notifications.
OntosightTM is designed to enrich and accelerate the research processes and decision-making. As a web-based platform, no installation is required so getting started is as simple as receiving your login.
Use Innoplexus’ full capabilities, including identifying connections between biological entities, predicting toxicologies, validating the biological activity of new molecules, estimating clinical trial costs, and assessing the competitive landscape to determine drug assets most likely to demonstrate efficacy, safety, and commercial success.
Access untapped KOL networks. Identify Top vs. Emerging KOLs and filter them by therapeutic area, location, publications, clinical trials, relationships with pharmaceutical competitors, and numerous customizable filters. Determine which KOLs to engage with based on four KOL archetypes Innoplexus has identified: Commercial, Clinical, Thought-leaders, and Public Speakers.
Accelerate the development of robust clinical trials by quickly comparing trials from over 100+ databases, including clinicaltrials.gov. Connect the outcomes of clinical trials, such as progression to subsequent phases, regulatory approval, and payer decisions with the trial parameters such as trial duration, sample sizes, endpoints, inclusion / exclusion criteria, and others to determine the optimal trial design.
Site Optimization & Enrollment
Endotype Response & Personalized Medicine